Can We Screen for Postpartum Depression Earlier?
Several studies suggest that screening during the first week postpartum may be helpful in identifying women at higher risk for experiencing postpartum depression.
Essential Reads: Mirtazapine (Remeron) and Pregnancy
While we have adequate data to support the use of SSRI and SNRI antidepressants during pregnancy, there is less data regarding other classes of antidepressants. Although we less commonly use mirtazapine in pregnancy, several studies have investigated the association between mirtazapine (Remeron) exposure during pregnancy and the risk of major congenital malformations. Risk of Congenital Malformations Danish Nationwide Cohort Study (2022): This study analyzed data from 895 pregnancies exposed to [...]
Phenomenology of Postpartum Psychosis: Preliminary Findings from MGHP3
The MGHP3 study provides key insights into the onset, duration, treatment, and characteristics of postpartum psychosis in a large, diverse cohort.
Prenatal Exposure to Cannabis and Risk of Autism in Children
Based on the findings of two meta-analyses and several large cohort studies, we cannot conclude that cannabis is “safe” for use during pregnancy. Data regarding risk for autism spectrum disorder is mixed.
Announcing “So Glad You Asked”: A Groundbreaking Podcast for Maternal Mental Health
We’re launching "So Glad You Asked," a groundbreaking podcast for maternal mental health, in 2025, and we want your feedback.
Essential Reads: Lithium and Breastfeeding (2024)
Because women with bipolar disorder are at high risk for relapse during the postpartum period, we typically recommend that women continue treatment with lithium throughout the postpartum period. While this intervention clearly decreases risk for postpartum psychiatric illness, the use of lithium while breastfeeding presents certain challenges.